October 2, 2017 | Magenta Medical, a medical device company specializing in the treatment of acute heart failure, has raised $15 million in a Series B financing round led by transcatheter hearts pump leader Abiomed Inc. and international venture capital firms Pitango Venture Capital (Israel) and JAFCO Co. (Japan.) Also contributing to the round are a group of private investors made up of industry and cardiovascular experts led by Professor Jacques Seguin. Seguin is a renowned cardiac surgeon, entrepreneur and founder of CoreValve Inc., a transcatheter developer acquired by medical technology leader Medtronic in 2009. He has since joined the Magenta Board of Directors. Magenta Medical was founded by Ehud Schwammenthal and Yosi Tuval in October 2012.